Sign In
Free Newsletter
Chesterfield pharma company enters $600M federal plea deal
Less than one month after former Indivior PLC CEO Shaun Thaxter pleaded guilty in federal court in Abingdon to a misdemeanor criminal charge related to the marketing of the Chesterfield County-based company’s opioid addiction treatment drug Suboxone, the company announced Friday it has entered a $600 million plea deal with the U.S. Justice Department, the […]
Ex Chesterfield pharma CEO pleads guilty in federal opioid treatment investigation
Shaun Thaxter, former CEO of Chesterfield County-based pharmaceutical manufacturer Indivior PLC, pleaded guilty Tuesday in federal court in Abingdon to a misdemeanor criminal charge related to the U.S Justice Department’s probe into the marketing of Suboxone, Indivior’s opioid addiction treatment drug. Thaxter pleaded guilty to one count of violating the Federal Food, Drug, and Cosmeti[...]
Trump administration chooses RVA pharma startup for $354M COVID-19 contract
Richmond-based drug manufacturing company Phlow Corp., which incorporated this year, announced Tuesday that the Trump administration has awarded it a $354 million, four-year contract to manufacture in the U.S. generic medicines and pharmaceutical ingredients needed to treat COVID-19, creating an American supply chain for medical products that are now made mostly in China and India. […]
Richmond pharmaceutical company expands into Canada
Richmond-based pharmaceutical company Kaléo announced Wednesday it is expanding its market to Canada, offering its epinephrine auto-injector Allerject. The product used to treat severe allergic reactions will be available in pharmacies across Canada starting May 19. In response to a shortage of EpiPen in Canada in 2018, Kaléo’s original epinephrine auto-injector Auvi-Q was available in [[...]
